Meeting Register Page

Updates from Roche on Phase II Generation HD2 study
The Generation HD2 trial is just about to start recruiting participants in the first of a total of 15 countries. In Europe Denmark, France, Germany, UK, Poland, Italy, Spain, Portugal and Switzerland will take part in the trial. From Roche Peter McColgan, MD PhD, and the Principal Investigator in Madrid, Spain, Dr. José Luis López-Sendón will provide the latest updates of the study and their research efforts in HD. After the presentations, there will be time for comments and questions.
* Required information